Emerald Mutual Fund Advisers Trust trimmed its holdings in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 14.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 166,007 shares of the company's stock after selling 28,326 shares during the quarter. Emerald Mutual Fund Advisers Trust owned 0.51% of Bowhead Specialty worth $5,897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in the business. Summit Investment Advisors Inc. raised its stake in Bowhead Specialty by 66.4% in the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock worth $43,000 after acquiring an additional 486 shares during the last quarter. New York State Common Retirement Fund purchased a new position in Bowhead Specialty during the 4th quarter worth approximately $64,000. US Bancorp DE acquired a new stake in Bowhead Specialty during the 4th quarter valued at approximately $76,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Bowhead Specialty in the 4th quarter valued at $107,000. Finally, Pictet Asset Management Holding SA acquired a new stake in shares of Bowhead Specialty in the fourth quarter worth $145,000.
Insiders Place Their Bets
In other news, Director Ava Schnidman purchased 1,493 shares of the stock in a transaction dated Friday, February 28th. The shares were purchased at an average cost of $33.41 per share, with a total value of $49,881.13. Following the completion of the purchase, the director now directly owns 1,893 shares of the company's stock, valued at approximately $63,245.13. The trade was a 373.25 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on BOW shares. Keefe, Bruyette & Woods lowered their price target on shares of Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. JMP Securities boosted their price target on Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. JPMorgan Chase & Co. raised their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 8th. Finally, Piper Sandler assumed coverage on shares of Bowhead Specialty in a report on Wednesday, April 16th. They set an "overweight" rating and a $44.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $37.17.
Get Our Latest Research Report on BOW
Bowhead Specialty Price Performance
Bowhead Specialty stock traded up $1.31 during trading on Friday, reaching $41.31. The company had a trading volume of 255,644 shares, compared to its average volume of 214,557. The firm's 50-day simple moving average is $38.08 and its 200 day simple moving average is $34.92. Bowhead Specialty Holdings Inc. has a 1-year low of $22.14 and a 1-year high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.07. The company had revenue of $184.77 million for the quarter, compared to analysts' expectations of $102.12 million. As a group, equities research analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current fiscal year.
Bowhead Specialty Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.